Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning Grants

University of Alberta

$25,000.00

Diabetes and Cancer Research Consortium, Banff 2011

EF 2010-11

Résumé
The purpose of this meeting is to provide a forum for people with expertise and who are actively involved in observational studies of diabetes and cancer, with particular focus on the potential modifying role of glucose-lowering therapies. We believe that an international collaboration of experts on this topic is a key element to future success in this area. Although information can be drawn from controlled clinical trials, much research on this topic will inevitably take the form of observational studies. The limitations of this approach are well established; however, observational studies have an essential role in hypothesis generation, and may potentially form the basis for future clinical trials. Invited participants have all independently conducted observational studies on this topic, with large clinical or population-based datasets. A central aim of the Diabetes and Cancer Research Consortium is to develop joint work-programs and, where possible, to analyze data derived from different databases in parallel. As such, the Consortium will enable discussions of consistent and optimal analytic approaches to various databases from around the world, with a goal to subsequent meta-analyses of our independent epidemiologic studies. This approach is particularly important given the limited power to detect differences in rates of site-specific cancers and/or limited exposure to newer glucose lowering therapies in the independent study samples. This meeting will bring together approximately 25 individuals with expertise in epidemiology, oncology, diabetes, and statistical modeling from Canada, the United States, the UK, Sweden, Denmark, and Finland. This meeting will be a follow-up to the initial Diabetes and Cancer Research Consortium meeting, held in Copenhagen, Denmark, in June 2010.
Programme
Planning Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
216970
Name
Johnson Jeffrey A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Planning Grants
Projecttitle
Diabetes and Cancer Research Consortium, Banff 2011
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Alberta
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Planning Grants
Keyworddelim
Cancer; Diabetes; Epidemiology; Glucose-Lowering Therapy; Pharmacoepidemiology
Abstract
The purpose of this meeting is to provide a forum for people with expertise and who are actively involved in observational studies of diabetes and cancer, with particular focus on the potential modifying role of glucose-lowering therapies. We believe that an international collaboration of experts on this topic is a key element to future success in this area. Although information can be drawn from controlled clinical trials, much research on this topic will inevitably take the form of observational studies. The limitations of this approach are well established; however, observational studies have an essential role in hypothesis generation, and may potentially form the basis for future clinical trials. Invited participants have all independently conducted observational studies on this topic, with large clinical or population-based datasets. A central aim of the Diabetes and Cancer Research Consortium is to develop joint work-programs and, where possible, to analyze data derived from different databases in parallel. As such, the Consortium will enable discussions of consistent and optimal analytic approaches to various databases from around the world, with a goal to subsequent meta-analyses of our independent epidemiologic studies. This approach is particularly important given the limited power to detect differences in rates of site-specific cancers and/or limited exposure to newer glucose lowering therapies in the independent study samples. This meeting will bring together approximately 25 individuals with expertise in epidemiology, oncology, diabetes, and statistical modeling from Canada, the United States, the UK, Sweden, Denmark, and Finland. This meeting will be a follow-up to the initial Diabetes and Cancer Research Consortium meeting, held in Copenhagen, Denmark, in June 2010.
Competitiondate
201010
Approvedterm2
1 yr 0 mth
Pinamesdelim
Johnson, Jeffrey A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $25,000~ $0~